Company intelligence / Profile preview

Huangshi Shixing Pharmaceutical

Ownership: Private
Employees: ~400
Development stage: Other

Overview

Huangshi Shixing Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. Founded in 1953 and based in Huangshi, Hubei Province, the company has established itself as a significant global supplier of antiviral agents, including acyclovir, ganciclovir, and valacyclovir. Their product portfolio also extends to cardiovascular medications and other therapeutic categories. The company operates GMP-compliant facilities and exports its products to numerous international markets, serving as a key partner in the global pharmaceutical supply chain.

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Huangshi Shixing Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huangshi Shixing Pharmaceutical.